2023 European Society of Cardiology guidelines on the management of cardiomyopathies
This article contextualises the 2023 European Society of Cardiology (ESC) guidelines for the management of cardiomyopathies for clinical practice in the Netherlands. The guideline addendum provides additional recommendations for situations where the ESC guidelines may not fully align with Dutch clinical practice. By endorsing the ESC guidelines through this addendum, the Netherlands Society of Cardiology (Nederlandse Vereniging Voor Cardiologie) supports its members in adhering to evidence-based management strategies for cardiomyopathies. As Dutch cardiologists generally adopt the ESC guidelines quickly, this contextualisation is essential for effective application thereof within the Dutch healthcare setting.
Authors
- Richard L. Braam
- Bas M. van Dalen (ORCID: https://orcid.org/0000-0002-8294-7008)
- Folkert W. Asselbergs (ORCID: https://orcid.org/0000-0002-1692-8669)
- Michelle Michels
- Stéphane Heymans (ORCID: https://orcid.org/0000-0001-9477-7803)
- Judith A. Groeneweg
- Moniek G.P.J. Cox (ORCID: https://orcid.org/0000-0003-2825-8428)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Maastricht University Medical Centre (NL)
- Gelre Hospitals (NL)
- Maastricht University (NL)
- Sint Franciscus Gasthuis (NL)
- Health Data Research UK (GB)
- Erasmus MC Cancer Institute (NL)
- University College London (GB)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1007/s12471-025-01955-2
- Citations
- 8
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- Amsterdam University Medical Centers